Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹1 Cr
Revenue (TTM)
₹0 Cr
Net Profit (TTM)
₹0 Cr
ROE
0 %
ROCE
0 %
P/E Ratio
2.9
P/B Ratio
-0.2
Industry P/E
--
EV/EBITDA
3.2
Div. Yield
0 %
Debt to Equity
-0.1
Book Value
₹-10.2
EPS
₹-0.1
Face value
10
Shares outstanding
3,000,000
CFO
--
EBITDA
--
Net Profit
--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BSE Sensex
| -15.4 | -11.9 | -15.9 | -5.8 | 6.7 | 7.4 | 11.0 |
|
BSE FMCG
| -16.7 | -10.4 | -15.0 | -13.0 | 0.6 | 5.5 | 8.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
No Review & Analysis are available.
Growing of other flowers, including production of cut flowers, flower buds and flower seeds
Incorporated
1993
Chairman
--
Managing Director
--
Headquarters
Vadodara, Gujarat
Website
--
Annual Reports
The P/E ratio of Valplus Biotech Ltd is 2.88 times as on 31-Jul-2002.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2005
|
0.00
|
0.00
|
|
2004
|
0.00
|
0.00
|
|
2003
|
0.00
|
0.00
|
|
2002
|
0.00
|
-0.07
|
|
2005
|
0.00
|
0.00
|
The 52-week high and low of Valplus Biotech Ltd are Rs -- and Rs -- as of 02-Apr-2026.
Valplus Biotech Ltd has a market capitalisation of ₹ 1 Cr as on 31-Jul-2002. As per SEBI classification, it is a company.
Before investing in Valplus Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.